Sagimet Biosciences Inc.
SGMT
$5.14
-$0.07-1.34%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/16/2026
-
MarketBeat
3/14/2026
-
MarketBeat
3/13/2026
-
MarketBeat
3/12/2026
-
TipRanks Financial Blog
3/11/2026
-
Seeking Alpha - Healthcare
3/11/2026
-
MarketBeat
3/11/2026
-
MarketBeat
3/11/2026
-
TipRanks Financial Blog
3/11/2026
-
TipRanks Financial Blog
3/11/2026
-
The Fly
3/11/2026
-
Globe Newswire
3/11/2026
-
Ticker Report
3/8/2026
-
MarketBeat
3/4/2026
-
MarketBeat
3/3/2026
-
Seeking Alpha: Transcripts
3/1/2026
-
MarketBeat
2/25/2026
-
Globe Newswire
2/16/2026
-
Ticker Report
2/15/2026
-
Simply Wall St
2/13/2026
-
Ticker Report
2/13/2026
-
MarketBeat
2/12/2026
-
MarketBeat
2/11/2026
-
MarketBeat
Assessing Sagimet Biosciences (SGMT) Valuation After Positive Denifanstat Phase 3 Acne Trial Results
2/5/2026
-
Simply Wall St
2/5/2026
-
Globe Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, March 11, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 4 and 8 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 561 8600
Address
155 Bovet Road
San Mateo, CA 94402
San Mateo, CA 94402
Country
Year Founded
Business Description
Sector
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from...
more